News & innovations in aesthetic medicine

We officially launched NOOĀNCE in September 2022, but the project had been in the making for over five years. For three years, we collaborated with biochemical engineers, dermatologists, and skin experts to develop a range of LED masks and LED & Laser (LLLT) helmets, combining advanced technology, comfort, and clinically proven effectiveness. We also formulated a line of topical skincare products designed to work in synergy with our LED devices, using the most thoroughly studied and scientifically validated active ingredients.

In the field of aesthetic medicine, a quiet revolution is emerging with the rise of integrative medicine. By combining traditional approaches from conventional medicine with alternative therapies, this practice aims to treat the patient holistically. This model finds a particular place in anti-aging medicine, where the focus is on improving quality of life, as well as on prevention and maintaining physical and mental balance.

Botulinum toxin has been used for medical purposes since 1975, but it is in the field of aesthetic medicine that botulinum toxin has seen a real revolution. In 2002, botulinum toxin, marketed under the name BOTOX, was approved by the Food and Drug Administration (FDA) for the treatment of wrinkles.

Two journeys, one shared ambition: to simplify the management of aesthetic clinics through digital innovation. Benoît, an engineer in medical imaging, and Bertrand, a specialist in finance and organization, co-founded iDocteur, a French software solution designed for aesthetic medical professionals.

Dr Hugues Cartier is a dermatologist at a medical centre with a clinical studies department, assisted by a team of young dermatologists. He is also an Associate Hospital Practitioner at the Centre Hospitalier d’Arras. Dr Sébastien Garson is a plastic surgeon practising in Senlis. A former president of the SOFCEP (Société Française des Chirurgiens Esthétiques Plasticiens), he is currently vice-president of the SNCPRE (Syndicat National de Chirurgie Plastique Reconstructrice et Esthétique) and president of Plastirisq.

The global exosomes market reached US$ 500m in 2024, with 60% for diagnostics and 40% for therapeutics with a gradual shift of the center of gravity towards therapeutics with an initial focus on cardiovascular, metabolic, oncological, respiratory and anti-inflammatory areas but are now augmenting their impact on age-related dermatological pathologies. It is scheduled to explode to US$ 3bn by 2030, eg a 28% Compounded Annual Growth Rate.

Benjamin Ascher, MD, is a board-certified plastic surgeon, member of the French, American, and International Societies of Plastic, Reconstructive and Aesthetic Surgery (SOFCPRE, SOFCEP, ASPS, ISAPS).
A former chief resident, Hospitals of Paris assistant and Chairman & Head of the “IENA Aesthetic Surgery Clinique” in Paris, France.

Innovation plays a crucial role in the evolution of dermatology and aesthetic medicine. Technological advances, like those made by Aerolase, are transforming patient care, making it more effective, more comfortable and more accessible. Today, presenting Aerolase's Neo Elite® laser means presenting a revolutionary device that redefines dermatological treatments.

With the advent of digital technology, it's natural to turn to the Internet for information about a professional, company or brand, in order to assess what's commonly known as their online reputation, or E-reputation. I often hear doctors say, whether at the agency or at the faculty: “Medical E-reputation is the rating on Google”.